Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00046176
What this trial is testing

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 240
Testing effectiveness (Phase 2)Ended earlyNCT03320876
What this trial is testing

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 122
Early research (Phase 1)Study completedNCT02266940
What this trial is testing

Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets

Who this might be right for
Healthy
Daiichi Sankyo 18
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableEnded earlyNCT02915991
What this trial is testing

User Evaluation Study of SyncVision System With Software v4.X

Who this might be right for
Coronary Artery Disease
Volcano Corporation 35
Testing effectiveness (Phase 2)Study completedNCT00044018
What this trial is testing

CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 102
Early research (Phase 1)Study completedNCT01134718
What this trial is testing

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 24
Early research (Phase 1)Study completedNCT03849690
What this trial is testing

A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Millennium Pharmaceuticals, Inc. 12
Post-approval studies (Phase 4)WithdrawnNCT03237260
What this trial is testing

An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Pennsylvania
Large-scale testing (Phase 3)Active Not RecruitingNCT06569420
What this trial is testing

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerALK-positiveSAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 275
Large-scale testing (Phase 3)Study completedNCT01739582
What this trial is testing

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 300
Post-approval studies (Phase 4)Study completedNCT01673724
What this trial is testing

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Sandoz 121
Early research (Phase 1)Study completedNCT06648824
What this trial is testing

Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants

Who this might be right for
Healthy Participants
Agios Pharmaceuticals, Inc. 20
Not applicableUnknownNCT04657380
What this trial is testing

A Mobile Application to Improve Case-management and Patient's Functioning in First Episode Psychosis

Who this might be right for
Psychosis; Episode
Hôpital le Vinatier 168
Early research (Phase 1)WithdrawnNCT01437280
What this trial is testing

GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers

Who this might be right for
TumorsSolid Tumors
Baylor College of Medicine
Large-scale testing (Phase 3)Study completedNCT00904280
What this trial is testing

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Who this might be right for
Cancers, PainLower Back Pain
Endo USA Inc., a Keenova Therapeutics Company 239
Testing effectiveness (Phase 2)Looking for participantsNCT06222879
What this trial is testing

Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT07177196
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy

Who this might be right for
Retinal Dystrophy
n-Lorem Foundation 1
Early research (Phase 1)Study completedNCT02581696
What this trial is testing

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

Who this might be right for
Peptic Ulcer
Boryung Pharmaceutical Co., Ltd 24
Early research (Phase 1)Ended earlyNCT05338346
What this trial is testing

ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorsHematological Malignancies
Antengene Discovery Limited 22
Next Page